Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder

@article{Austin1991DopamineBA,
  title={Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder},
  author={L. Austin and R. Lydiard and J. Ballenger and B. Cohen and E. Ellinwood},
  journal={Biological Psychiatry},
  year={1991},
  volume={30},
  pages={225-232}
}
  • L. Austin, R. Lydiard, +2 authors E. Ellinwood
  • Published 1991
  • Psychology, Medicine
  • Biological Psychiatry
    • While many data suggest that Obsessive-Compulsive Disorder (OCD) is an illness accompanied by dysregulation of the serotonergic system, interesting clinical evidence and animal studies also suggest possible dysregulation of the dopaminergic (DA) system. In order to determine whether clomipramine (CMI), an antiobsessional agent, is capable of altering DA function, we performed a neuroleptic radioreceptor assay (NRRA) on plasma samples from OCD patients before and after treatment in a double… CONTINUE READING
    View on Elsevier
    doi.org
    46 Citations
    Highly Influencial Citations
    1
    Background Citations
    12
    Results Citations
    1
    46 Citations
    Citation Type

    Citation Type

    THE PATHOPHYSIOLOGY AND GENETICS OF OBSESSIVE-COMPULSIVE DISORDER
    • 5
    • PDF
    Obsessive-Compulsive Disorder in Elderly Patients
    • 5
    Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
    • 73
    Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
    • 173
    Pharmacological Treatment of Childhood Obsessive-Compulsive Disorder: From Theory to Practice
    • 34
    Fluvoxamine and sulpiride in comorbid obsessive–compulsive disorder and gilles de la tourette syndrome
    • 38
    Intravenous clomipramine in severe and refractory obsessive-compulsive disorder.
    • 4
    Management of schizophrenia with obsessive-compulsive features.
    • 43
    An update on the pharmacological treatment of obsessive-compulsive disorder
    • 39
    A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder
    • 106

    References

    SHOWING 1-10 OF 33 REFERENCES
    Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    • 131
    Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    • 284
    Obsessive-compulsive disorder and serotonin: Is there a connection?
    • 312
    Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report.
    • 31
    Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology
    • 341
    Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
    • 279
    Clomipramine in obsessive-compulsive disorder
    • 82
    Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    • 102
    Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    • 453
    Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    • 303